These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 30337923)

  • 1. Nanoparticle Vaccines Against Infectious Diseases.
    Pati R; Shevtsov M; Sonawane A
    Front Immunol; 2018; 9():2224. PubMed ID: 30337923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging skin-targeted drug delivery strategies to engineer immunity: A focus on infectious diseases.
    Korkmaz E; Balmert SC; Carey CD; Erdos G; Falo LD
    Expert Opin Drug Deliv; 2021 Feb; 18(2):151-167. PubMed ID: 32924651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in nanocarrier-aided mucosal vaccination.
    Kammona O; Bourganis V; Karamanidou T; Kiparissides C
    Nanomedicine (Lond); 2017 May; 12(9):1057-1074. PubMed ID: 28440707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarriers for systemic and mucosal vaccine delivery.
    Shahiwala A; Vyas TK; Amiji MM
    Recent Pat Drug Deliv Formul; 2007; 1(1):1-9. PubMed ID: 19075870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine delivery using nanoparticles.
    Gregory AE; Titball R; Williamson D
    Front Cell Infect Microbiol; 2013; 3():13. PubMed ID: 23532930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advancements in protein nanoparticle vaccine platforms to combat infectious disease.
    Butkovich N; Li E; Ramirez A; Burkhardt AM; Wang SW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1681. PubMed ID: 33164326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccine technologies: From whole organisms to rationally designed protein assemblies.
    Karch CP; Burkhard P
    Biochem Pharmacol; 2016 Nov; 120():1-14. PubMed ID: 27157411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-based subunit nanovaccines.
    Skwarczynski M; Toth I
    Curr Drug Deliv; 2011 May; 8(3):282-9. PubMed ID: 21291373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
    Jin JW; Tang SQ; Rong MZ; Zhang MQ
    Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticles and Vaccine Development.
    Kheirollahpour M; Mehrabi M; Dounighi NM; Mohammadi M; Masoudi A
    Pharm Nanotechnol; 2020; 8(1):6-21. PubMed ID: 31647394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticulate Carriers Used as Vaccine Adjuvant Delivery Systems.
    Wang N; Qian R; Liu T; Wu T; Wang T
    Crit Rev Ther Drug Carrier Syst; 2019; 36(5):449-484. PubMed ID: 32421952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prime-boost immunization strategies for infectious diseases.
    McShane H
    Curr Opin Mol Ther; 2002 Feb; 4(1):23-7. PubMed ID: 11883691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-Based Modulation of the Immune System.
    Fang RH; Zhang L
    Annu Rev Chem Biomol Eng; 2016 Jun; 7():305-26. PubMed ID: 27146556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: Nanoparticle Vaccines Against Infectious Diseases.
    Reljic R; González-Fernández Á
    Front Immunol; 2019; 10():2615. PubMed ID: 31787982
    [No Abstract]   [Full Text] [Related]  

  • 15. Gold nanoparticles for preparation of antibodies and vaccines against infectious diseases.
    Dykman LA
    Expert Rev Vaccines; 2020 May; 19(5):465-477. PubMed ID: 32306785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micro- and nanoparticulates for DNA vaccine delivery.
    Farris E; Brown DM; Ramer-Tait AE; Pannier AK
    Exp Biol Med (Maywood); 2016 May; 241(9):919-29. PubMed ID: 27048557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combatting infectious diseases; nanotechnology as a platform for rational vaccine design.
    van Riet E; Ainai A; Suzuki T; Kersten G; Hasegawa H
    Adv Drug Deliv Rev; 2014 Jul; 74():28-34. PubMed ID: 24862579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.
    Maruggi G; Zhang C; Li J; Ulmer JB; Yu D
    Mol Ther; 2019 Apr; 27(4):757-772. PubMed ID: 30803823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines.
    Criscuolo E; Caputo V; Diotti RA; Sautto GA; Kirchenbaum GA; Clementi N
    J Immunol Res; 2019; 2019():8303648. PubMed ID: 30949518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Strategies for Mucosal Vaccination.
    Longet S; Lundahl MLE; Lavelle EC
    Bioconjug Chem; 2018 Mar; 29(3):613-623. PubMed ID: 29300463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.